{{Rsnum
|rsid=34097093
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Orientation=plus
|Chromosome=19
|position=41012465
|Gene=CYP2B6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CYP2B6
}}{{PharmGKB
|RSID=rs34097093
|Name_s=CYP2B6*28, CYP2B61132C>T, CYP2B6:R378X
|Gene_s=CYP2A7P1, CYP2B6
|Feature=
|Evidence=PubMed ID:17235330
|Annotation=The CYP2B6:1132C>T variant results in a truncated protein and high plasma levels of efavirenz in patients.
|Drugs=efavirenz
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162355646
}}
Suspect:  Variation suspected to be false positive due to artifacts of the presence of a paralogous sequence in the genome  (Musumeci et al. 2010) (Sudmant et al. 2010) or evidence suggested sequencing error or computation artifacts. 

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}